Avid Radiopharmaceuticals

At Avid, a wholly owned subsidiary of Eli Lilly and Company, our mission is to develop new molecular imaging agents capable of changing the medical management of significant chronic human diseases. We have assembled an outstanding management team with extensive imaging and CNS development experience to help make pre-symptomatic disease detection a reality. Avids pipeline of imaging compounds has the potential to dramatically alter the clinical course of challenging conditions such as Alzheimers disease, Dementia with Lewy Bodies, Parkinsons disease and Diabetes Mellitus. This may be possible because our molecular imaging compounds may be able to detect the first stages...

Radiopharmaceuticals,pet imaging,dementia,and diabetes

Avid radiopharmaceuticals operates in the Pharmaceutical manufacturing industry.

Avid radiopharmaceuticals's revenue is 11m - 100m

Avid radiopharmaceuticals has 51 - 200 employees.